rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Balaxi Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Mar ' 22 Sep ' 21 Sep ' 20 Mar ' 20 Sep ' 19
Sales 38.60 62.69 43.36 24.85 20.78
Operating profit 6.83 10.23 10.03 4.39 2.07
Interest 0.04 0.02 - - -
Gross profit 8.31 11.44 12.02 6.26 3.01
EPS (Rs) 6.00 8.47 8.97 4.32 2.17
Half yearly  results in details
Mar ' 22 Sep ' 21 Sep ' 20 Mar ' 20 Sep ' 19
Other income 1.52 1.22 1.99 1.87 0.94
Stock adjustment - - - - -
Raw material 27.92 49.00 31.52 - -
Power and fuel - - - - -
Employee expenses 1.59 1.29 0.88 0.93 0.83
Excise - - - - -
Admin and selling expenses 2.26 2.17 - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses - - 0.93 19.53 17.88
Provisions made - - - - -
Depreciation 0.16 0.09 0.04 0.01 -
Taxation 2.15 2.88 3.01 1.93 0.84
Net profit / loss 6.00 8.47 8.97 4.32 2.17
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 10.00 10.00 10.00 10.00 10.00
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 17.69 16.32 23.13 17.67 9.97
GPM (%) 20.71 17.90 26.50 23.42 13.87
NPM (%) 14.95 13.25 19.78 16.18 10.00

Mutual Fund Selector

Find the fund that is right for you
Close
Add Balaxi Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Balaxi Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close